HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunological evaluation of 15 children with non-Hodgkin lymphoma.

Abstract
In the present study, 15 children with non-Hodgkin lymphoma have been immunologically evaluated by the following parameters on peripheral blood (PB) lymphocytes: phytohemagglutinin responsiveness (PHA-r); non-immune rosette formation with sheep red blood cells (RF-L) as T-cell marker; presence of surface immunoglobulins (sIg-L) as B-cell marker; serum immunoglobulins levels (IgA, IgM, IgG). Our patients (pts) have been divided in two groups: the first one includes 10 children without PB involvement; the second one includes 5 pts with bone-marrow and PB invasion. From our data it appears that: 1) the majority of pts of the first group presented normal values of membrane markers; PHA-r was impaired in 4/8 pts; 2) in pts with PB invasion absolute number of B and "null" cells was always abnormal and PHA-r altered; 3) in the second group of pts, a "null" cell origin can be suggested by the high percentage and absolute number of cells without surface markers. In our opinion, the high incidence of "null" cells represents the most relevant question: whether they are cells deprived of specific markers, or endowed with markers not identifiable by our current techniques, remains to be established.
AuthorsC Rosanda-Vadalà, B De Bernardi, M Pasino, G P Tonini, A Comelli, P G Mori, P Perutelli, L Massimo
JournalHaematology and blood transfusion (Haematol Blood Transfus) Vol. 20 Pg. 221-6 ( 1977) ISSN: 0171-7111 [Print] Germany
PMID580250 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulins
  • Receptors, Antigen, B-Cell
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunoglobulins (analysis)
  • Lymphocyte Activation
  • Lymphocytes (immunology)
  • Lymphoma (classification, immunology, pathology)
  • Male
  • Prognosis
  • Receptors, Antigen, B-Cell (analysis)
  • Rosette Formation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: